Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B F Cole

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The Cancer Journal From Scientific American|July 1, 1995
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survivalR D Gelber, B F Cole, A Goldhirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision makingB F Cole, P Solal-Céligny, R D Gelber, et al.
Neurology|April 1, 1996
A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumorsM J Glantz, B F Cole, M H Friedberg, et al.
Neurology|May 24, 2000
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of NeurologyM J Glantz, B F Cole, P A Forsyth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group Study 8821S K Parsons, S Gelber, B F Cole, et al.
Blood|June 14, 2000
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA)N Mounier, C Haioun, B F Cole, et al.
The Journal of Urology|March 29, 2000
A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parametersT Schwaab, J A Heaney, A R Schned, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomasM J Glantz, H Choy, C M Kearns, et al.
Journal of the National Cancer Institute|June 24, 1998
Exposure to breast milk in infancy and adult breast cancer riskL Titus-Ernstoff, K M Egan, P A Newcomb, et al.
Lancet (London, England)|April 20, 1996
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survivalR D Gelber, B F Cole, A Goldhirsch, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Cancer Journal From Scientific American|July 1, 1995
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survivalR D Gelber, B F Cole, A Goldhirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision makingB F Cole, P Solal-Céligny, R D Gelber, et al.
Neurology|April 1, 1996
A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumorsM J Glantz, B F Cole, M H Friedberg, et al.
Neurology|May 24, 2000
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of NeurologyM J Glantz, B F Cole, P A Forsyth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group Study 8821S K Parsons, S Gelber, B F Cole, et al.
Blood|June 14, 2000
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA)N Mounier, C Haioun, B F Cole, et al.
The Journal of Urology|March 29, 2000
A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parametersT Schwaab, J A Heaney, A R Schned, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomasM J Glantz, H Choy, C M Kearns, et al.
Journal of the National Cancer Institute|June 24, 1998
Exposure to breast milk in infancy and adult breast cancer riskL Titus-Ernstoff, K M Egan, P A Newcomb, et al.
Lancet (London, England)|April 20, 1996
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survivalR D Gelber, B F Cole, A Goldhirsch, et al.
Pageof 6